VRNA Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Merck & Co., Inc. - Mentions: MRK

Merck Completes Acquisition of Verona Pharma

25 days ago - By: Verona Pharma plc

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

a month ago - By: Verona Pharma plc

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

2 months ago - By: Verona Pharma plc

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

2 months ago - By: Bloomberg - Mentions: MRK

Merck Taps US Investment-Grade Bond Market for Verona Purchase

2 months ago - By: Benzinga

Looking Into Verona Pharma's Recent Short Interest

4 months ago - By: Benzinga

Is the Market Bullish or Bearish on Verona Pharma?

2 months ago - By: Yahoo Finance - Mentions: MRK

Here’s How Wall Street is Reacting to Verona Pharma (VRNA)’s Acquisition

3 months ago - By: Zacks Investment Research

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

3 months ago - By: Zacks Investment Research - Mentions: JNJ MRK UTHR

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

3 months ago - By: Zacks Investment Research - Mentions: MRK MRNA SMMT

Merck Stock Down 4% Since Q2 Results: How to Play the Stock

3 months ago - By: The Motley Fool - Mentions: MSTR SMCI MRK

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today

3 months ago - By: Zacks Investment Research - Mentions: AZN MRK

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

3 months ago - By: The Motley Fool - Mentions: MRK

Does This Move Make Merck Stock a Buy?

3 months ago - By: Halper Sadeh LLC - Mentions: DALN RGLD

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

4 months ago - By: Zacks Investment Research - Mentions: VIPS FUTU ALKT

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

4 months ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer

4 months ago - By: Halper Sadeh LLC - Mentions: KLG MGRM SONN

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

4 months ago - By: Kahn Swick & Foti, LLC

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

4 months ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

4 months ago - By: Yahoo Finance - Mentions: MRK

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

4 months ago - By: Yahoo Finance - Mentions: NVDA HG=F SBUX CRWV ...

Stock market today: Dow, S&P 500, Nasdaq jump as Nvidia's surge to milestone boosts tech

4 months ago - By: Halper Sadeh LLC

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

4 months ago - By: Yahoo Finance - Mentions: NVDA SBUX HG=F CRWV ...

Stock market today: Dow, S&P 500, Nasdaq edge higher as Nvidia's market cap hits $4T, Trump unveils more tariff letters

4 months ago - By: Brodsky & Smith LLC - Mentions: OLO GNTY MRC MRK ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

4 months ago - By: Investor's Business Daily - Mentions: MRK

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

4 months ago - By: Stocktwits - Mentions: MRK JDOC

VERONA PHARMA PLC - ADR (VRNA) Stock News

VRNA Latest News, Press Relases and Analysis

Merck Completes Acquisition of Verona Pharma

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

Merck Taps US Investment-Grade Bond Market for Verona Purchase

Looking Into Verona Pharma's Recent Short Interest

Is the Market Bullish or Bearish on Verona Pharma?

Here’s How Wall Street is Reacting to Verona Pharma (VRNA)’s Acquisition

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

Merck Stock Down 4% Since Q2 Results: How to Play the Stock

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

Does This Move Make Merck Stock a Buy?

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

Weathering Market Uncertainty? Bet on VIPS, ALKT, FUTU & VRNA Now

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

Stock market today: Dow, S&P 500, Nasdaq jump as Nvidia's surge to milestone boosts tech

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

Stock market today: Dow, S&P 500, Nasdaq edge higher as Nvidia's market cap hits $4T, Trump unveils more tariff letters

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline